13F-HR filed by BML Capital Management, LLC
BML Capital Management, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-05, with 29 holding rows worth $169,949,505.
- Accession
- 0001754960-24-000545
- Filer
- CIK 1616824
- Filed
- 2024-11-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 29 entries on the cover page, a total value of $169,949,505 stated on the cover page (in dollars after the unit check, H1), rows summing to $169,949,505 with VALUE read as dollars as filed, 13F file number 028-22948. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| iShares 0-3 Month Treasury Bond ETF | 46436E718 | SHS | 270,000 | $27,194,400 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 335,000 | $22,552,200 | dollars as filed | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 6,650,000 | $22,277,500 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 14,250,000 | $16,387,500 | dollars as filed | |
| SPDR Bloomberg 1-3 Month T-Bill ETF | 78468R663 | SHS | 175,000 | $16,066,750 | dollars as filed | |
| ADVERUM BIOTECHNOLOGIES INC | 00773U207 | COM NEW | 2,268,064 | $15,921,809 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 211,752 | $6,416,086 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 5,749,432 | $6,151,892 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 3,457,395 | $5,877,572 | dollars as filed | |
| ORAMED PHARMACEUTICALS INC | 68403P203 | COM NEW | 2,186,191 | $5,334,306 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 4,100,002 | $4,182,002 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 2,000,000 | $4,120,000 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 2,093,232 | $3,014,045 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 1,688,772 | $2,516,270 | dollars as filed | |
| ASTROTECH CORP | 046484309 | COM | 220,410 | $1,761,076 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 1,136,091 | $1,726,858 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 60,000 | $1,424,400 | dollars as filed | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 723,288 | $1,251,288 | dollars as filed | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 228,500 | $1,071,665 | dollars as filed | |
| LISATA THERAPEUTICS INC | 128058302 | COM | 284,669 | $854,007 | dollars as filed | |
| PIERIS PHARMACEUTICALS INC | 720795202 | COM | 42,130 | $698,515 | dollars as filed | |
| CALCIMEDICA INC | 38942Q202 | COM NEW | 153,887 | $681,719 | dollars as filed | |
| ALLOVIR INC | 019818103 | COM | 603,086 | $487,595 | dollars as filed | |
| TALIS BIOMEDICAL CORP | 87424L207 | COM NEW | 248,702 | $460,099 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 150,000 | $451,500 | dollars as filed | |
| FORTE BIOSCIENCES INC | 34962G208 | COMMON STOCK | 70,468 | $393,916 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 276,465 | $378,757 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W108 | COM | 180,000 | $261,000 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 19,760 | $34,778 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001754960-24-000545 | this filing | 2024-11-05 | acceptance time not in the bulk data set |